Donepezil fails to enhance cognitive abilities in breast cancer survivors: Phase III trial results

FHS
May 21, 2024
3:49 am

Many breast cancer survivors report cancer-related cognitive impairment following chemotherapy, although prevalence rates and severity vary.

CMS Star Ratings Unreliable for Surgical Quality?

Higher CMS hospital star ratings generally were associated with better surgical outcomes, but there was wide variability within each star-rating group, suggesting its utility for

June 19, 2024

Empowering Change: How Hologic is Shaping the Future of Women’s Healthcare

Hologic, Inc. is a global medical technology innovator primarily focused on improving women’s health and well-being through early detection and treatment.

March 8, 2024

Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary – Biotech Investments

EQS-News: Rentschler Biopharma SE / Key word(s): Personnel Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary 02.05.2024 / 14:10 CET/CEST The issuer

May 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.